Citadel Advisors
GMDA

Citadel Advisors’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Citadel Advisors’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,890
Closed -$682 – 15855
2024
Q1 		$682 Buy
+18,890
New +$6.46K ﹤0.01% 14272
2023
Q1 		– Sell
-30,163
Closed -$44.1K – 15786
2022
Q4 		$38.9K Buy
30,163
+4,813
+19% +$7.61K ﹤0.01% 12450
2022
Q3 		$40K Buy
+25,350
New +$57.8K ﹤0.01% 11766
2022
Q2 		– Sell
-32,577
Closed -$82.8K – 14445
2022
Q1 		$135K Sell
32,577
-26,508
-45% -$88.9K ﹤0.01% 11972
2021
Q4 		$150K Buy
59,085
+13,010
+28% +$42.9K ﹤0.01% 12259
2021
Q3 		$181K Buy
46,075
+6,449
+16% +$32.2K ﹤0.01% 12122
2021
Q2 		$254K Sell
39,626
-7,440
-16% -$51.3K ﹤0.01% 11665
2021
Q1 		$381K Buy
47,066
+29,926
+175% +$275K ﹤0.01% 10302
2020
Q4 		$144K Buy
17,140
+1,635
+11% +$11.1K ﹤0.01% 9976
2020
Q3 		$64K Buy
+15,505
New +$66.1K ﹤0.01% 9506

Other funds holding GMDA

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's GMDA Position: Q2 2024 in Review

Citadel Advisors sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 18,890 shares — an estimated $682 sold.

Citadel Advisors first reported a position in GMDA in Q3 2020 and held it in 10 quarters. The position peaked at $381K in Q1 2021. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.

  • Citadel Advisors reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 18,890 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $682.
  • Citadel Advisors first reported a position in Gamida Cell Ltd. Ordinary Shares in Q3 2020 and held it in 10 quarters.
  • Citadel Advisors's Gamida Cell Ltd. Ordinary Shares position peaked at $381K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.